GgoogleRU first seen 3 d ago, last 3 d ago, peak #4

New European Guidance on Resmetirom and Semaglutide for MASH

Original: mash

European medical societies EASL, EASD and EASO have issued new guidance on treating MASH, a severe form of fatty liver disease. The recommendations cover the use of resmetirom and semaglutide, reflecting growing attention to newly approved drug therapies for a condition long managed mainly through lifestyle changes.

Why now: Newly issued guidance on drug treatment for fatty liver disease is drawing attention from medical professionals and patients.

EASLEASDEASOresmetiromsemaglutide

Open on google →

Rank over time, top of the chart is #1. 2 snapshots from 3 d ago to 3 d ago.

Evidence

• EASL-EASD-EASO Issue New Guidance on Resmetirom and Semaglutide for MASH · Medical Dialogues

Elsewhere

• GgoogleFR #4 · 5 d ago

API: https://socialmediatrends-api.osmike.com/v1/trends/2099698